Pulsatile Insulin Infusion Therapy in Patients With Type 1 and Type 2 Diabetes Mellitus
Conditions: Diabetes Mellitus, Type 2; Diabetes Mellitus, Type 1 Interventions: Drug: 3 hours humulin R 100 IU/mL PIT; Drug: 2 hours humulin R 100 IU/mL PIT Sponsors: Sciema UG; Innovative Diabetes Treatment Studies LLC. Not yet recruiting
Source: ClinicalTrials.gov - Category: Research Source Type: clinical trials
More News: Diabetes | Diabetes Mellitus | Diabetes Type 1 | Diabetes Type 2 | Endocrinology | Insulin | Research